Serum Institute of India Limited - Product Pipeline Review - 2015

Nov, 2015   |   34  Pages   |   ISBN : GMDHC07751CDB   |   Global Markets Direct   |   Format : PDF

Summary

Serum Institute of India Limited - Product Pipeline Review - 2015, provides an overview of the Serum Institute of India Limiteds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Serum Institute of India Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes inclu

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Serum Institute of India Limited Snapshot 5
Serum Institute of India Limited Overview 5
Key Information 5
Key Facts 5
Serum Institute of India Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Serum Institute of India Limited - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Serum Institute of India Limited - Pipeline Products Glance 13
Serum Institute of India Limited - Late Stage Pipeline Products 13
Phase III Products/Combination Treatment Modalities 13
Serum Institute of India Limited - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Serum Institute of India Limited - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Serum Institute of India Limited - Drug Profiles 17
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ErepoXen 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
SII RMab 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SIILPCV-10 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
diphtheria + tetanus + pertussis (acellular) vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
meningococcal polysaccharide [serogroup X] + tetanus (monovalent) vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Serum Institute of India Limited - Pipeline Analysis 23
Serum Institute of India Limited - Pipeline Products by Target 23
Serum Institute of India Limited - Pipeline Products by Route of Administration 24
Serum Institute of India Limited - Pipeline Products by Molecule Type 25
Serum Institute of India Limited - Pipeline Products by Mechanism of Action 26
Serum Institute of India Limited - Recent Pipeline Updates 27
Serum Institute of India Limited - Dormant Projects 30
Serum Institute of India Limited - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 33
Disclaimer 34

List of Tables
Serum Institute of India Limited, Key Information 5
Serum Institute of India Limited, Key Facts 5
Serum Institute of India Limited - Pipeline by Indication, 2015 7
Serum Institute of India Limited - Pipeline by Stage of Development, 2015 8
Serum Institute of India Limited - Monotherapy Products in Pipeline, 2015 9
Serum Institute of India Limited - Combination Treatment Modalities in Pipeline, 2015 10
Serum Institute of India Limited - Partnered Products in Pipeline, 2015 11
Serum Institute of India Limited - Partnered Products/ Combination Treatment Modalities, 2015 12
Serum Institute of India Limited - Phase III, 2015 13
Serum Institute of India Limited - Phase II, 2015 14
Serum Institute of India Limited - Phase I, 2015 15
Serum Institute of India Limited - Preclinical, 2015 16
Serum Institute of India Limited - Pipeline by Target, 2015 23
Serum Institute of India Limited - Pipeline by Route of Administration, 2015 24
Serum Institute of India Limited - Pipeline by Molecule Type, 2015 25
Serum Institute of India Limited - Pipeline Products by Mechanism of Action, 2015 26
Serum Institute of India Limited - Recent Pipeline Updates, 2015 27
Serum Institute of India Limited - Dormant Developmental Projects,2015 30
Serum Institute of India Limited, Other Locations 31
Serum Institute of India Limited, Subsidiaries 32

List of Figures
Serum Institute of India Limited - Pipeline by Top 10 Indication, 2015 7
Serum Institute of India Limited - Pipeline by Stage of Development, 2015 8
Serum Institute of India Limited - Monotherapy Products in Pipeline, 2015 9
Serum Institute of India Limited - Pipeline by Top 10 Target, 2015 23
Serum Institute of India Limited - Pipeline by Top 10 Route of Administration, 2015 24
Serum Institute of India Limited - Pipeline by Top 10 Molecule Type, 2015 25

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Follow Us On: